News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ) Touts Its Pharma R&D Efforts for China


5/28/2013 9:03:56 AM

by Richard Daverman, PhD

May 24, 2013 -- Janssen Pharmaceutical Companies, a division of Johnson & Johnson, did something this week that big pharmas haven't done very often in the last few years: it bragged about its recent drug discovery success and made predictions about its future progress. The company said it had four new medical entities awaiting approval in China along with four line extensions. It expects to file an additional nine NMEs and six line extensions for approval by 2017. More details....

Stock Symbol: (NYSE: JNJ)


Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES